Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04958135 · ClinicalTrials.gov registry record · Phase 1
Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants
A Phase 1 study, sponsored by Alexion Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 18
- Enrollment target
NCT04958135 is a Phase 1 study that has completed, run by Alexion Pharmaceuticals. The registered enrollment target is 18 participants.
The verdict
NCT04958135, a Phase 1 study, has completed, sponsored by Alexion Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of a high-fat, high-caloric meal on the pharmacokinetics (PK) of acoramidis in healthy adult participants following an oral single dose administration of acoramidis. Blood sampling for PK assessment will include measures for acoramidis and its metabolite, acoramidis acyl glucuronide (acoramidis-AG).
Interventions
- DRUG Acoramidis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-05-30 |
| Est. Completion | 2021-08-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04958135
The ClinicalTrials.gov registry entry for NCT04958135 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alexion Pharmaceuticals, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Acoramidis is the first listed.
NCT04958135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04958135 about?
NCT04958135 is a clinical study titled "Study to Assess the Effect of Food on a Single Dose of Acoramidis in Healthy Adult Participants". The purpose of this study is to determine the effect of a high-fat, high-caloric meal on the pharmacokinetics (PK) of acoramidis in healthy adult participants following an oral single dose administration of acoramidis. Blood sampling for PK assessment will include measures for acoramidis and its met...
What is the current status of trial NCT04958135?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 18 participants. The study started on 2021-05-30. Estimated completion is 2021-08-04.
What interventions are being tested in trial NCT04958135?
The interventions under investigation include: Acoramidis (DRUG).
Who is sponsoring clinical trial NCT04958135?
This trial is sponsored by Alexion Pharmaceuticals, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.